Associated Papers
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.
Christopoulos P et al.
Translational Lung Cancer Research, 2021
34164264 (PubMed )
Supplement: tlcr-10-05-2118-supplementary.pdf
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
Dietz S et al.
Ebiomedicine, 2020
Select a paper to view details